MedTrace Logo

Impact of Previous Treatment of HCV Patients by DAADs on Covid-19 Disease Frequency and Severity

NCT04729153 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-02-03

No results posted yet for this study

Summary

Evaluate effect of DAADs on covid-19 disease.

Conditions

  • Covid19

Interventions

DRUG

DAAD Compound

Sofosbuvir , Daclatasvir and ribavirin

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-28
Primary Completion
2022-02-28
Completion
2022-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04729153 on ClinicalTrials.gov